Skip to main content
. 2023 Sep 15;17:85. doi: 10.1186/s40246-023-00532-1

Fig. 1.

Fig. 1

A MECP2 expression levels for RTT, MDS and control individuals obtained by RNAseq. B MeCP2 intensity levels for RTT, MDS and control individuals obtained by proteomics. C Pearson’s correlation between the severity score of RTT patients and MeCP2 levels